Immunitybio Inc (IBRX)

$3.98 0.06 (1.49%)

16:00 EST IBRX Stock Quote Delayed 30 Minutes

7 Small-Cap Stocks With Massive Growth Potential

By Louis Navellier and the InvestorPlace Research Staff Nov 9, 2023

Small-cap stocks can generate oversized returns, particularly when they hit on a new product or provide a unique service.

3 Biotech Moonshots to Bet on the Future of Health

3 Very Oversold Biotech Stocks to Buy Right Now

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

Volume:

Previous Close -

Market Cap 1.56B

PE Ratio -3.79

EPS -1.05

Volume (Avg. Vol.) 3.50M

Day's Range $3.97 - $4.28

52-Week Range $1.21 - $7.10

Dividend & Yield N/A (N/A)

IBRX Stock Predictions, Articles, and Immunitybio Inc News

From InvestorPlace
From the Web

7 High-Risk, High-Reward Stocks to Buy in June

By Larry Ramer, InvestorPlace Contributor Jun 12, 2023

These are the best high-risk, high-reward stocks to buy in June. They can all generate big profits for investors.

Why Is ImmunityBio (IBRX) Stock Down 54% Today?

By William White, InvestorPlace Writer May 11, 2023

ImmunityBio (IBRX) stock is falling on Thursday after the company got a response letter from the FDA concerning its bladder cancer treatment.

The 7 Most Undervalued Growth Stocks for Your May Buy List

By Larry Ramer, InvestorPlace Contributor May 8, 2023

Economic data and a short-covering rally suggest that the outlook for undervalued growth stocks is improving.

3 Stocks to Buy That Could Be the Next Biotech Breakthrough

By Larry Ramer, InvestorPlace Contributor Apr 16, 2023

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

7 Unknown Biotech Stocks That Could Rocket in 2023

By Faisal Humayun, InvestorPlace Contributor Sep 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

7 Cheap Biotech Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor May 19, 2022

These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treatments in the pipelines.

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline Apr 5, 2022

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

Immunitybio Inc (IBRX)

7 Small-Cap Stocks With Massive Growth Potential

3 Biotech Moonshots to Bet on the Future of Health

3 Very Oversold Biotech Stocks to Buy Right Now

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Immunitybio Inc (IBRX)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

IBRX Stock Predictions, Articles, and Immunitybio Inc News

Subscriber Sign in